<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01278875</url>
  </required_header>
  <id_info>
    <org_study_id>10-208-BMA</org_study_id>
    <nct_id>NCT01278875</nct_id>
  </id_info>
  <brief_title>Function of High Density Lipoproteins in Acute Coronary Syndromes</brief_title>
  <acronym>HDL_ACS</acronym>
  <official_title>High Density Lipoprotein Function in Acute Coronary Syndromes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>McGill University Health Centre/Research Institute of the McGill University Health Centre</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>McGill University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>McGill University Health Centre/Research Institute of the McGill University Health Centre</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      High density lipoproteins (HDL) have many effects that protect against cardiovascular&#xD;
      diseases. In an acute heart attack (acute coronary syndrome -ACS), HDL change in composition&#xD;
      and structure, reflecting the inflammatory environment that accompanies an ACS. The&#xD;
      investigators will examine the function of HDL during an ACS and again when the patient has&#xD;
      recovered.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High density lipoproteins (HDL) have pleiotropic effects associated with protection against&#xD;
      atherosclerosis. These effects include cellular cholesterol efflux, anti-inflammatory and&#xD;
      anti-oxidant effects, increase in nitric acid (NO) production from vascular endothelial cells&#xD;
      and differentiation of endothelial progenitor cells for repair at sites of vascular injury.&#xD;
      The measurement of the cholesterol mass within HDL (HDL-C) does not provide an adequate&#xD;
      measure of HDL function. The investigators therefore propose to test and validate biomarkers&#xD;
      of HDL function in patients with acute coronary syndromes (ACS).&#xD;
&#xD;
      Hypothesis: HDL lose their cardiovascular protective functions in ACS. The investigators&#xD;
      hypothesize that these changes are transient and partly normalize within 12 weeks. In this&#xD;
      proposal, the investigators will examine the function of HDL in acute coronary syndromes&#xD;
      (ACS) and 12 weeks later, in the recovery phase. Acute coronary syndromes are characterized&#xD;
      by an acute inflammatory reaction, a marked decrease in HDL in plasma and a shift of the HDL&#xD;
      proteome to an inflammatory phenotype.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Anticipated">December 2025</completion_date>
  <primary_completion_date type="Anticipated">December 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HDL-mediated cellular cholesterol efflux</measure>
    <time_frame>12 weeks</time_frame>
    <description>Biomarkers of HDL function</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">65</enrollment>
  <condition>Acute Coronary Syndrome</condition>
  <arm_group>
    <arm_group_label>Acute Coronary Syndrome</arm_group_label>
    <description>Subjects with ACS within 72 hours of clinical presentation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stable CAD subjects</arm_group_label>
    <description>Patients with stable, chronic CAD</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control subjects</arm_group_label>
    <description>Healthy individuals</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum Plasma HDL isolated by ultracentrifugation&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients presenting to hospital with an acute coronary syndrome, within 72 hours&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Men and women 18-80 years of age&#xD;
&#xD;
          -  Acute Coronary Syndrome within 72 hours of presentation&#xD;
&#xD;
          -  Elevated tropinins (T or I)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Refusal to participate&#xD;
&#xD;
          -  Inability to return for a 12 week follow-up visit&#xD;
&#xD;
          -  Hemodynamic instability requiring vasopressor support, mechanical ventricular assist&#xD;
             devices, the need for coronary artery bypass surgery&#xD;
&#xD;
          -  Lack of documented atherosclerotic CAD&#xD;
&#xD;
          -  Uncontrolled hypertension&#xD;
&#xD;
          -  Triglycerides≥5mmol/L&#xD;
&#xD;
          -  Severe obesity (BMI≥35)&#xD;
&#xD;
          -  Alcohol intake&gt;21 drinks/week&#xD;
&#xD;
          -  Presence of thyroid, hepatic, or renal disease&#xD;
&#xD;
          -  Autoimmune disease or any chronic or acute infectious or inflammatory illness&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacques Genest, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>McGill University Health Centre/Research Institute of the McGill University Health Centre</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>McGill University Health Centre</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H3A 1A1</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 18, 2011</study_first_submitted>
  <study_first_submitted_qc>January 18, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2011</study_first_posted>
  <last_update_submitted>September 22, 2021</last_update_submitted>
  <last_update_submitted_qc>September 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>McGill University Health Centre/Research Institute of the McGill University Health Centre</investigator_affiliation>
    <investigator_full_name>Jacques Genest</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>High density lipoproteins</keyword>
  <keyword>Acute coronary syndromes</keyword>
  <keyword>Cellular cholesterol efflux</keyword>
  <keyword>HDL: proteomics</keyword>
  <keyword>Nitric Acid production</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acute Coronary Syndrome</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

